bvad114.875
A staggering 90% of vegetarians and vegans worldwide are estimated to have low B12 levels
Semaglutide is a GLP-1 receptor agonist that works at the hormonal level to reduce appetite, slow digestion, and quiet the constant mental negotiation around food
It is an investigational drug that exists only within clinical trials sponsored by Eli Lilly
For patients with metabolic syndrome, non-alcoholic fatty liver disease, or insulin resistance where visceral fat is the primary cardiovascular and metabolic driver, this mechanism distinction is clinically meaningful
42,47,49,50 Treatment Considerations for the Patient Taking a GLP-1 RA Given the multifaceted role of AT in tissue homeostasis, a comprehensive regenerative approach should be considered for patients experiencing GLP-1 RA-MWL, rather than an approach focused on volumetric correction